GFGLENHER
LIVE

Serial Number

88862519

Owner

G+FLAS Life Sciences

Attorney

Mark J. Liss

Filing Date

Apr 7, 2020

Add to watchlist:

No watchlists yet
View on USPTO

GFGLENHER Trademark

Serial Number: 88862519 • Registration: 6542068

GFGLENHER is a trademark filed by G+FLAS Life Sciences on April 7, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

G+FLAS Life Sciences (6 trademarks)

Seoul 08790 , KR

Entity Type: 03

Trademark Details

Filing Date

April 7, 2020

Registration Date

November 2, 2021

Published for Opposition

August 17, 2021

Goods & Services

Reagents for use in veterinary genetic testing for medical use; Diagnostic preparations for veterinary purposes; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Protein arrays for medical diagnosis purposes; Ferments for medical or veterinary use; Biological preparations for the treatment of breast cancer; Nutritive substances for microorganisms for medical purposes; Therapeutic pharmaceutical for the treatment of breast cancer; Reagents for medical use; Diagnostic preparations for medical purposes for detecting mutations in genes; Stem cells for medical purposes; Diagnostic preparations for medical purposes; Enzymes for medical purposes; Pharmaceutical preparations for treating breast cancer; Therapeutic pharmaceutical for the treatment of rare genetic disorder

Filing History

REGISTERED-PRINCIPAL REGISTER
Nov 2, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 18, 2021 CRFA
ASSIGNED TO LIE
Jun 17, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 2, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 4, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 4, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 4, 2021 CNSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jun 26, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Jun 26, 2020 GNSL
SUSPENSION LETTER WRITTEN
Jun 26, 2020 CNSL
ASSIGNED TO EXAMINER
Jun 25, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2020 NWOS
NEW APPLICATION ENTERED
Apr 10, 2020 NWAP